Pinnacle Wealth Planning Services’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Pinnacle Wealth Planning Services's AMPH Position: Q2 2026 in Review
Pinnacle Wealth Planning Services increased its Amphastar Pharmaceuticals (AMPH) stake by 312% in Q2 2026, buying an estimated $17.8K and bringing the position to 1,165 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1706.
Pinnacle Wealth Planning Services first reported a position in AMPH in Q4 2020 and has held it in 4 quarters since. The position peaked at $43.3K in Q4 2025. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Pinnacle Wealth Planning Services held 1,165 shares of Amphastar Pharmaceuticals worth $23.5K as of Q2 2026.
- Pinnacle Wealth Planning Services bought 882 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $17.8K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1706 holding.
- Pinnacle Wealth Planning Services first reported a position in Amphastar Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
- Pinnacle Wealth Planning Services's Amphastar Pharmaceuticals position peaked at $43.3K in Q4 2025.
- 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.